Possible role of caffeine in autism spectrum disorders, a new testable hypothesis.
Ghanizadeh
Ahmad
A
D058907:Adenosine A1 Receptor Agonists / Q000494:pharmacology; D058908:Adenosine A2 Receptor Agonists / Q000494:pharmacology; D058917:Adenosine A2 Receptor Antagonists / Q000494:pharmacology; D000818:Animals; D002110:Caffeine / Q000009:adverse effects / Q000494:pharmacology*; D002648:Child; D002659:Child Development Disorders, Pervasive / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D058915:Purinergic P1 Receptor Antagonists / Q000009:adverse effects / Q000494:pharmacology*; D019956:Stereotypic Movement Disorder / Q000188:drug therapy
D058907:Adenosine A1 Receptor Agonists; D058908:Adenosine A2 Receptor Agonists; D058917:Adenosine A2 Receptor Antagonists; D058915:Purinergic P1 Receptor Antagonists; D002110:Caffeine